Silence Therapeutics plc Financial Assets At Amortised Cost
Silence Therapeutics plc (SLN) had Financial Assets At Amortised Cost of GBP 284.00 thousand as of 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes
ifrs-full:FinancialAssetsAtAmortisedCost · last filed 2024-03-13
- 2023-12-31: Financial Assets At Amortised Cost 284.00K GBP.
- 2022-12-31: Financial Assets At Amortised Cost 16.61M GBP.
- 2021-12-31: Financial Assets At Amortised Cost 301.00K GBP.
- 2020-12-31: Financial Assets At Amortised Cost 10.30M GBP.
| Period end | Financial Assets At Amortised Cost |
|---|---|
| 2023-12-31 | 284.00K GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 16.61M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 301.00K GBP 20-F · filed 2023-03-15 |
| 2020-12-31 | 10.30M GBP 20-F · filed 2022-03-17 |
| 2019-12-31 | 20.28M GBP 20-F/A · filed 2021-04-29 |
| 2018-12-31 | 5.32M GBP 20-F/A · filed 2021-04-29 |